Schizophrenia is a long-term mental health condition that causes a range of different psychological symptoms. These include: hallucinations (hearing or seeing things that do not exist), delusions (unusual beliefs that are not based on reality and often contradict the evidence), muddled thoughts based on the hallucinations or delusions, and changes in behaviour. Doctors describe schizophrenia as a psychotic illness. This means that sometimes a person may not be able to distinguish their own thoughts and ideas from reality.

Our schizophrenia Blogs

Antipsychotic effectiveness: the numbers don’t lie, check the scoreboard

Screen Shot 2018-03-12 at 15.16.57

Students and Teachers from the King’s College London PNoMH Distance Learning MSc summarise a major new meta-analysis that brings together the last 60 years of placebo-controlled antipsychotic drug trials in acute schizophrenia.

[read the full story...]

Risk factors and peripheral biomarkers for schizophrenia spectrum disorders

This 'umbrella review' aimed to systematically appraise the meta-analyses of observational studies on risk factors and peripheral biomarkers for schizophrenia spectrum disorders.

Marcus Munafo considers the findings of a systematic review of meta-analyses of observational studies, which looks at risk factors and peripheral biomarkers for psychotic disorders on the schizophrenia spectrum.

[read the full story...]

Antidepressants for depression in schizophrenia: when good-enough evidence is good enough


Carmine Pariante is positive about a recent systematic review and meta-analysis of antidepressants for the treatment of depression in schizophrenia.

[read the full story...]

Staff views on digital self-management of severe mental illness


Laura Hemming presents a recent qualitative study of staff views on the use of the Internet and smartphones for digital self-management of severe mental health problems.

[read the full story...]

Antipsychotic combinations for schizophrenia: safe and effective?


Elena Marcus presents the findings of an updated Cochrane review on antipsychotic combinations for schizophrenia.

[read the full story...]

Personal well-being networks for severe mental illness: the importance of being social


The University College London Mental Health Masters students summarise a recent exploratory study on personal well-being networks, social capital and severe mental illness.

[read the full story...]


Screen Shot 2014-11-25 at 17.36.49

Sameer Jauhar and Paul Morrison consider the revised Understanding Psychosis and Schizophrenia report from the British Psychological Society Division of Clinical Psychology, which includes updated sections on definitions, aetiology and treatment.

[read the full story...]

Antipsychotics for acute treatment of first episode schizophrenia


Elwira Lubos writes her debut blog on a recent systematic review with pairwise and network meta-analyses, looking at antipsychotic drugs for the acute treatment of patients with first episode schizophrenia.

[read the full story...]

People with severe mental illness die younger and things are getting worse


Judith Harrison publishes her debut blog on a recent cohort study in the British Journal of Psychiatry, which shows that the “mortality gap” is increasing for people with bipolar disorder and schizophrenia.

[read the full story...]

Should people with schizophrenia be offered depot antipsychotics as first line treatment?


Murtada Alsaif reports on a new nationwide Swedish cohort study that explores the real-world effectiveness of oral and depot antipsychotics for people with schizophrenia.

[read the full story...]